Allele-specific antibodies to Plasmodium vivax merozoite surface protein-1: prevalence and inverse relationship to haemoglobin levels during infection
Autor: | Cor Jesus Fernandes Fontes, Chris Drakeley, Marcus V. G. Lacerda, Cristiane Guimarães Morais, Matheus França Freire, Érika Martins Braga, Luiza Carvalho Mourão, Nuno Sepúlveda |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Adult Male Antigenicity 030231 tropical medicine Plasmodium vivax Antibodies Protozoan Enzyme-Linked Immunosorbent Assay Anaemia Epitope Antibodies 03 medical and health sciences Epitopes Hemoglobins 0302 clinical medicine Antigen Seroepidemiologic Studies Malaria Vivax Humans Allele Polymorphism Alleles Merozoite Surface Protein 1 biology Research Haplotype Middle Aged biology.organism_classification Virology 3. Good health 030104 developmental biology Infectious Diseases Parasitology Immunoglobulin G Immunology biology.protein MSP-1 Female Antibody |
Zdroj: | Malaria Journal |
ISSN: | 1475-2875 |
Popis: | Background Antigenic polymorphisms are considered as one of the main strategies employed by malaria parasites to escape from the host immune responses after infections. Merozoite surface protein-1 (MSP-1) of Plasmodium vivax, a promising vaccine candidate, is a highly polymorphic protein whose immune recognition is not well understood. Methods and results The IgG responses to conserved (MSP-119) and polymorphic (block 2 and block 10) epitopes of PvMSP-1 were evaluated in 141 P. vivax infected patients. Ten recombinant proteins corresponding to block 2 (variants BR07, BP29, BP39, BP30, BEL) and block 10 (BR07, BP29, BP39, BP01, BP13) often observed in Brazilian P. vivax isolates were assessed by ELISA in order to determine levels of specific antibodies and their respective seroprevalence. The magnitude and the frequency of variant-specific responses were very low, except for BR07 variant (>40%), which was the predominant haplotype as revealed by block 10 PvMSP-1 gene sequencing. By contrast, 89% of patients had IgG against the C-terminal conserved domain (PvMSP-119), confirming the high antigenicity of this protein. Using multiple linear and logistic regression models, there was evidence for a negative association between levels of haemoglobin and several IgG antibodies against block 2 variant antigens, with the strongest association being observed for BP39 allelic version. This variant was also found to increase the odds of anaemia in these patients. Conclusions These findings may have implications for vaccine development and represent an important step towards a better understanding of the polymorphic PvMSP-1 domain as potential targets of vaccine development. These data highlight the importance of extending the study of these polymorphic epitopes of PvMSP-1 to different epidemiological settings. Electronic supplementary material The online version of this article (doi:10.1186/s12936-016-1612-z) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |